v565
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT03010787)
Timeline
Indications
Mechanism of action
- TNF-alphaINHIBITOR
TNF inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- v565
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03705117 | Phase 1 | May 23, 2017 | VHsquared Ltd. |
| NCT02976129 | Phase 2 | Dec 1, 2016 | VHsquared Ltd. |
| NCT03010787 | Phase 1 | Sep 1, 2015 | VHsquared Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VHsquared Ltd. | For profit | 3 | 3 | 2 | 2015 |
1 organizations
Page 1 / 1